🔎 Trials Near Me

Gara Jalqabaatti › Sklerosis Baay’ee › Illinois

Qorannoo klinikaalii Sklerosis Baay’ee Illinois keessatti

Qorannoo 19 Sklerosis Baay’ee f Illinois keessatti hirmaatuu jiru.

Magaalota Illinois keessatti

Takkalaa qorannoo (Ingiliffa)

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

  • TG Therapeutics Investigational Trial Site, Chicago
  • TG Therapeutics Investigational Trial Site, Chicago
  • TG Therapeutics Investigational Trial Site, Evanston
  • fi 1 dabalataa
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT06433752

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

  • Rush University Medical Center, Chicago
  • University of Chicago Medical Center, Chicago
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07002034

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  • Consultants in Neurology- Site Number : 8400020, Northbrook
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT07325292

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis

  • University of Chicago Medical Center, Chicago
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 10 hanga 17 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT06408259

Evaluation of the Safety and Efficacy of a Full-Body Electrostimulation Garment for Individuals With Neurological and Neuromuscular Conditions That Cause Spasticity, Hyperreflexia, and Pain

  • Shirley Ryan AbilityLab, Chicago
Namoota walitti qabaa jira
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07132775

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  • Northwestern Memorial Hospital, Chicago
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 29-Ado-2026 · NCT07225504

Ocrevus Zunovo for MS: Mixed Methods

  • Northwestern Memorial Hospital, Chicago
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT07710105

Exercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility Device

  • University of Illinois at Chicago, Chicago
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT06410261

Functional Balance Intervention in Multiple Sclerosis

  • University of Illinois at Chicago, Chicago
Namoota walitti qabaa jira
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT06341023

Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

  • University of Illinois at Chicago, Chicago
Namoota walitti qabaa jira
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 04-Wax-2026 · NCT05051618

Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters

  • Disability Participation and Quality of Life (DPQOL) Laboratory, Urbana
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Cam-2026 · NCT07167680

Nomad P-KAFO Study

  • Shirley Ryan AbilityLab, Chicago
Namoota walitti qabaa jira
Umuriin 18 hanga 89 · Saalaa hunda · Haaromfame 11-Cam-2026 · NCT05644522

Intermittent Hypoxia in Persons With Multiple Sclerosis

  • Shirley Ryan AbilityLab, Chicago
Namoota walitti qabaa jira
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 20-Bit-2026 · NCT06276634

People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

  • Northwestern Memorial Hospital, Chicago
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT07207148

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

  • Northwestern Memorial Hospital, Chicago
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT07225361

Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS

  • Shirley Ryan AbilityLab, Chicago
Namoota walitti qabaa jira
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 23-Gur-2026 · NCT06390930

Home Based Functional Balance Intervention for Multiple Sclerosis

  • University of Illinois at Chicago, Chicago
Namoota walitti qabaa jira
Umuriin 40 hanga 90 · Saalaa hunda · Haaromfame 21-Ama-2026 · NCT07355387

An Individualized-health eLibrary App for People With Multiple Sclerosis

  • University of Illinois Urbana-Champaign, Champaign
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Hag-2025 · NCT05124600

Remote Evaluation of MIND Diet

  • University of Illinois Urbana-Champaign, Urbana
Namoota walitti qabaa jira
Umuriin 18 hanga 64 · Saalaa hunda · Haaromfame 27-Wax-2024 · NCT06450977

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.